Nu Skin Enterprises (NUS) Proxy filing summary

Executive summary

• Annual Meeting scheduled for May 28, 2026, with voting on director elections, executive compensation, incentive plan, and auditor ratification.

• Board recommends voting for all nine director nominees, approval of executive compensation, the amended incentive plan, and auditor ratification.

• Proxy materials distributed starting April 15, 2026; record date for voting is March 31, 2026.

Voting matters and shareholder proposals

• Proposals include election of nine directors, advisory vote on executive compensation, approval of the Amended and Restated 2024 Omnibus Incentive Plan, and ratification of PricewaterhouseCoopers LLP as auditor for 2026.

• Board recommends voting for all proposals.

• Shareholder proposals for the 2027 meeting must be submitted by December 16, 2026, for proxy inclusion.

Board of directors and corporate governance

• Board consists of nine members, with 33% diversity in gender and/or race/ethnicity.

• Separate Chairman (Lund) and CEO (Napierski) roles; Lead Independent Director (Campbell) designated.

• 75% of directors are independent; all committees are composed solely of independent directors.

• Annual board and committee evaluations are conducted, with a third-party facilitator used in 2025.

• Mandatory retirement age of 77 for directors joining after 2023.

• Equity retention, hedging, and pledging policies in place for directors and executives.